LABORATORY NEWS
-
Nucleai And GoPath Diagnostics Announce Strategic Collaboration To Provide Integrated AI-Powered Digital Pathology Solutions For Clinical Research And Diagnostic Applications
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics, a leading full-service digital pathology and molecular diagnostics laboratory.
- SOPHiA GENETICS And Strand Life Sciences Announce New Strategic Partnership
- INTERACT Coalition Formed To Advance Patient Access To Genetic Testing For Hereditary Cancer Risk
- Cepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test
- Descartes Labs Accelerates Growth With Strategic Acquisition Of Geosite
ARCHIVED NEWSLETTER
- 04.09.24 -- Pivoting To Allogeneic CAR-T Therapies With Celyad Oncology's CMO, Dr. Charlie Morris
- 03.26.24 -- Notable Public Comments On The FDA's Proposed Regulation For Laboratory Developed Tests
- 03.12.24 -- FDA's CBER Issues Final Guidance For CAR T Cell Products
- 02.27.24 -- FDA Issues Final Guidance: Reformulating Drug Products That Contain Carbomers Manufactured With Benzene
- 02.13.24 -- FDA Issues Draft Guidance For Cell & Gene Therapy Potency Assurance
This website uses cookies to ensure you get the best experience on our website. Learn more